One common complication of these conditions is heart failure with preserved ejection fraction (HFpEF), a condition with a poor prognosis and life-limiting symptoms
Ludwig, MD, PhD Harvard Medical School After 15 years of research in partnership with experts from Stanford and UCLA, we developed BuildLeaf as a safer, more effective evolution of Tirzepatide
Understanding the GLP-1 eligibility criteria can help you have more informed conversations with your healthcare provider about whether this treatment path makes sense for your unique health situation
The medication works by enhancing insulin secretion in a glucose-dependent manner, suppressing glucagon release, and slowing gastric emptying, which collectively improve glycemic control and promote weight loss
Your GP, diabetes specialist nurse, and consultant should work collaboratively to optimise your treatment plan
Cancer patients going through chemo represent another group with documented benefits